Kidswell Bio Corporation
4584.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | ¥5,082,053 | ¥2,431,235 | ¥2,776,240 | ¥1,569,231 |
| % Growth | 109% | -12.4% | 76.9% | – |
| Cost of Goods Sold | ¥3,442,830 | ¥1,391,852 | ¥1,250,553 | ¥550,357 |
| Gross Profit | ¥1,639,223 | ¥1,039,383 | ¥1,525,687 | ¥1,018,874 |
| % Margin | 32.3% | 42.8% | 55% | 64.9% |
| R&D Expenses | ¥767,877 | ¥1,453,349 | ¥1,216,349 | ¥903,062 |
| G&A Expenses | ¥207,145 | ¥163,963 | ¥182,930 | ¥101,902 |
| SG&A Expenses | ¥207,145 | ¥163,963 | ¥182,930 | ¥101,902 |
| Sales & Mktg Exp. | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Operating Expenses | ¥636,318 | ¥757,668 | ¥677,337 | ¥665,048 |
| Operating Expenses | ¥1,611,340 | ¥2,374,980 | ¥2,076,616 | ¥1,670,012 |
| Operating Income | ¥27,883 | -¥1,335,597 | -¥550,929 | -¥651,139 |
| % Margin | 0.5% | -54.9% | -19.8% | -41.5% |
| Other Income/Exp. Net | ¥44,984 | -¥84,930 | -¥105,295 | ¥101,486 |
| Pre-Tax Income | ¥72,867 | -¥1,420,527 | -¥656,224 | -¥549,653 |
| Tax Expense | ¥94,008 | ¥1,551 | ¥1,210 | ¥1,210 |
| Net Income | -¥21,140 | -¥1,422,078 | -¥657,434 | -¥550,863 |
| % Margin | -0.4% | -58.5% | -23.7% | -35.1% |
| EPS | -0.52 | -40.23 | -20.77 | -17.86 |
| % Growth | 98.7% | -93.7% | -16.3% | – |
| EPS Diluted | -0.52 | -40.23 | -20.77 | -17.86 |
| Weighted Avg Shares Out | 40,503 | 35,345 | 31,654 | 30,851 |
| Weighted Avg Shares Out Dil | 40,503 | 35,345 | 31,654 | 30,851 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥767 | ¥8 | ¥12 | ¥936 |
| Interest Expense | ¥42,495 | ¥38,784 | ¥34,836 | ¥15,460 |
| Depreciation & Amortization | ¥900 | ¥921 | ¥932 | ¥2,300 |
| EBITDA | ¥116,264 | -¥1,380,821 | -¥620,453 | -¥531,893 |
| % Margin | 2.3% | -56.8% | -22.3% | -33.9% |